|
Carcinoma Articles
Carcinoma News : Important dog is ill Wed, 02 Jul 2008 09:14:54 GMT UroToday.com - The presence of a systemic inflammatory reaction, represented by C-reactive protein (CRP), has been recognized as one of the negative prognostic factors in various malignancies.Carcinoma News : The Natural History Of Bladder Carcinoma In Situ After Initial Response To Bacillus Calmete-Gúerin Immunotherapy Mon, 30 Jun 2008 09:15:32 GMT ORLANDO, FL (UroToday.com) - The authors explored patterns of recurrence, muscle invasion, and disease specific mortality in patients with bladder carcinoma in situ (CIS) who responded to an induction course with intravesical BCG immunotherapy.Kidney cancer vaccine falls short in clinical trial: study Fri, 04 Jul 2008 02:18:46 GMT A new kidney cancer vaccine failed in last-phase clinical trials to improve the odds of avoiding remission after tumour-removing surgery, according to a study released Friday.Orwigsburg man blasts cancer by coaching wife Thu, 03 Jul 2008 22:44:18 GMT ASHLAND — At this time last year, Steven Huber of Orwigsburg was in the midst of one of the best of his many fine trapshooting seasons.DGAP-News: WILEX AG: Phase III ARISER study with RENCAREX: patient recruitment successfully completed Thu, 03 Jul 2008 12:43:02 GMT Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer / publisher is solely responsible for the content of this announcement.ORIGINAL ARTICLE: Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer Wed, 02 Jul 2008 21:30:43 GMT This phase 2 trial investigated the efficacy of motesanib diphosphate, an orally active inhibitor of VEGF receptors, in patients with advanced differentiated thyroid cancer. None of the patients had had a response to conventional treatment. No patient had a complete response, but 14% had a partial response, with a median duration of 32 weeks. Motesanib diphosphate is an option for patients with ...My Pharmiweb.com Thu, 03 Jul 2008 13:22:10 GMT New Anti-Keratin Antibodies Introduced by AnaSpec AnaSpec Inc. Posted on:02 Jul 08 San Jose, CA –July 2nd, 2008 AnaSpec has introduced two keratin antibodies that recognize both the intact and caspase digested N-terminal of K18 and K19 at Asp237.Introgen seeks US & European approval for Advexin Thu, 03 Jul 2008 09:47:29 GMT Introgen Therapeutics, Inc. submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) requesting marketing approval for Advexin p53 therapy to treat recurrent, refractory head and neck cancer.9-year-old tri-athlete spins into action for prostate cancer Thu, 03 Jul 2008 07:02:50 GMT CHICAGO — Winter Vinecki, a 9-year-old from Gaylord, learned quickly that life is unpredictable.Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in ... Tue, 01 Jul 2008 11:00:00 GMT Agennix Incorporated today announced the publication of final results from a Phase 2 monotherapy trial with talactoferrin alfa in patients who had failed previous treatment for advanced or metastatic renal cell carcinoma .Introgen: Advexin to face regulatory hurdles and increasing skepticism Thu, 03 Jul 2008 01:27:53 GMT Introgen Therapeutics has submitted marketing authorization applications for Advexin p53 therapy on both sides of the Atlantic. However, Introgen may struggle to convince the regulatory authorities that the gene therapy drug will offer an improvement in the treatment of head and neck cancer.Skin Cancer Scare for Fresno's Police Chief Wed, 02 Jul 2008 17:59:40 GMT Doctors removed skin cancer from the left side of Chief Jerry Dyer's face. And they say it's not life threatening.Low Use Of Medical Check-Ups For Intestinal Cancer Wed, 02 Jul 2008 10:12:32 GMT Only 20% of persons aged over 55 use colonoscopies for early detection of cancer, even though the statutory health insurance funds have covered the costs since 2002. This was shown by an analysis of the Bavarian Colonoscopy Database published in the current edition of Deutsches Arzteblatt International (Dtsch Arztebl Int 2008; 105(24): 434-40). http://www.aerzteblatt.de/v4/archiv/pdf.Pseudosarcomatous Fibromyxoid Tumor Of The Bladder Wed, 02 Jul 2008 09:15:04 GMT UroToday.com - We recently reported on the workup and treatment of a benign bladder lesion termed pseudosarcomatous fibromyxoid tumor of the bladder. One of goals of the manuscript was the description of conservative surgical treatment of localized bladder lesions, which could be malignant or benign. Benign lesions include leiomyoma, pseudosarcomatous fibromyxoid tumor, among others.Yeast-Based Vaccine Induces Immune Responses And Reduces Tumor Size In Mice Wed, 02 Jul 2008 10:12:59 GMT Scientists have found that vaccination with a heat-killed, nontoxic yeast that is genetically engineered to manufacture a common tumor protein can induce specific and repeated anti-tumor immune responses in mice. Vaccination extends overall survival and reduces tumor size in mice that have been injected with cancer cells displaying the same protein that was engineered into the yeast.Back in the running Wed, 02 Jul 2008 08:15:49 GMT Central Catholic grad Frances Koons is a cancer survivor -- and an Olympic hopeful. Central Catholic grad Frances Koons is a cancer survivor -- and an Olympic hopeful.Popular aquarium sea lion dies during surgery Wed, 02 Jul 2008 07:28:50 GMT VANCOUVER - One of the Vancouver Aquarium's most popular animals, a 15-year-old male Steller sea lion named Tag, died early Tuesday during an operation for oral cancer. UPDATE: Fresno Police Dept. releases details of Chief Dyer's skin cancer Tue, 01 Jul 2008 22:40:10 GMT As KSEE 24.com first reported, Fresno Police Chief Jerry Dyer was treated for skin cancer last month. Today, the police department released details, saying Chief Dyer had a non-life threatening form of skin cancer that was surgically removed. Click on the story link to read the entire news release from the police department.Medical check-ups for intestinal cancer are hardly used Tue, 01 Jul 2008 13:09:26 GMT Only 20% of persons aged over 55 use colonoscopies for early detection of cancer, even though the statutory health insurance funds have covered the costs since 2002. This was shown by an analysis of the Bavarian Colonoscopy Database published in the current edition of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2008; 105(24): 434-40).Yeast-Based Vaccine Induces Immune Responses and Reduces Tumor Size in Mice Tue, 01 Jul 2008 13:45:17 GMT Scientists have found that vaccination with a heat-killed, nontoxic yeast that is genetically engineered to manufacture a common tumor protein can induce specific and repeated anti-tumor immune responses in mice.Yeast-based vaccine induces immune responses and reduces tumor size in mice Tue, 01 Jul 2008 22:30:33 GMT Scientists have found that vaccination with a heat-killed, non-toxic yeast that is genetically engineered to manufacture a common tumor protein can induce specific and repeated anti-tumor immune responses in mice.New Drug Therapy Attacks Cancers Tue, 01 Jul 2008 13:15:17 GMT A new targeted drug therapy developed at The Institute of Cancer Research is showing positive results in killing tumour cells of some common cancers in the laboratory, according to a study published in Clinical Cancer Research today (July 1).Yeast-based Vaccine Induces Immune Responses and Reduces Tumor Size in Mice Tue, 01 Jul 2008 14:02:11 GMT Scientists have found that vaccination with a heat-killed, non-toxic yeast that is genetically engineered to manufacture a common tumor protein can induce specific and repeated anti-tumor immune responses in mice. Vaccination extends overall survival and reduces tumor size in mice that have been injected with cancer cells displaying the same protein that was engineered into the yeast.Percutaneous Radiofrequency Ablation Shows Promise In The Treatment Of Lung Tumours Tue, 01 Jul 2008 11:13:42 GMT Percutaneous radiofrequency ablation - a minimally invasive treatment technique that heats and destroys cancer cells - achieves a high rate of sustained complete responses in selected patients with lung tumours, according to results from the first prospective study of patients treated with technique. Tumours in the lungs are common.A skin-deep dilemma: Sunscreen Tue, 01 Jul 2008 06:47:33 GMT There was a time, not all that long ago, when the sun was fun and all you had to know about sunscreen was which one would make you more Baywatchable: the coconut-scented oil or the coconut-scented lotion?Safe summer fun in the sun Tue, 01 Jul 2008 07:49:00 GMT After returning from a vacation at the beach, I am concerned about the number of adults who appear unconcerned about protecting their skin from the sun's harmful rays. Adults serve as role models to children by the way they treat their skin. Remember to teach children the importance of using sunscreen and sunblocks when playing outdoors.Young Valley woman battling breast cancer Tue, 01 Jul 2008 01:29:12 GMT Michelle Wilsey was your average young woman enjoying her twenties, until last August when she felt a lump in her breast and had a doctor check it out during her annual exam in September. The doctor told her it was normal for her age, telling Michelle she just had dense breasts.Introgen stock rises as company seeks FDA approval of cancer drug Mon, 30 Jun 2008 16:34:10 GMT Shares of Introgen Therapeutics Inc. rose more than 11 percent in early trading Monday on news that the company has applied with the U.S. Food and Drug Administration to market its newest cancer drug. (INGN)Liver Phase I Results Presented At WCIO 2008 & Best Of ASCO(R) Mon, 30 Jun 2008 17:12:41 GMT Celsion Corporation (NASDAQ: CLN) announced that the interim results from its second Phase I liver cancer confirmation study of ThermoDox in combination with Radio Frequency Ablation (RFA) treating patients with primary and metastatic liver cancer were presented at both Oral and Poster presentation at the WCIO 2008 and Best of ASCO® conference.John Challis: Young man defies death Mon, 30 Jun 2008 21:38:24 GMT Online refer: Hear from John himself. Watch an audio slideshow by Times' photographer Christina Baird at www.timesonline.com. Freedom baseball coach Steve Wetzel started an organization with John Challis to aid other cancer patients: The John Challis Courage For Life Foundation.Prognostic Value Of Re-TURB Of High Risk Non Invasive Bladder Cancer Sat, 28 Jun 2008 11:13:07 GMT ORLANDO, FL (UroToday.com) - The authors evaluated the usefulness of second TURB and whether pathological outcomes of ReTUR have a prognostic impact on recurrence and progression of primitive T1G3 bladder cancer. In this study patients with newly diagnosed T1G3 Transitional cell carcinoma of bladder underwent ReTUR 4-6 weeks following the initial TUR.New Data Show Preemptive Treatment May Significantly Reduce Skin Toxicities In Patients Receiving Vectibix(R) ... Mon, 30 Jun 2008 10:14:32 GMT Amgen (NASDAQ: AMGN) announced updated results from the "STEPP" (Skin Toxicity Evaluation Protocol with Panitumumab) trial, the first prospective study to examine differences between preemptive and reactive skin treatment for skin toxicities in metastatic colorectal cancer (mCRC) patients receiving epidermal growth factor receptor (EGFr) therapy.Challis becomes Rays' special guest Sun, 29 Jun 2008 01:00:41 GMT Challis becomes Rays' special guestSummer sun has hidden dangers Sun, 29 Jun 2008 22:20:16 GMT I am pale. Not peaches and cream like Nicole Kidman, either. So I went to Heavenly Skin, a medical laser skin care center in Florence, to research sun damage for this story, thinking my skin would have very little sun damage. Boy, was I ever wrong.Your Eyes Need UV Protection, Too Sat, 28 Jun 2008 23:11:02 GMT Good sunglasses can protect you from eyelid cancer and macular degeneration.Local briefs Fri, 27 Jun 2008 14:39:33 GMT Shriver fundraiser: Friends and family of Scott Shriver, 27, of Willis, are hosting a golf tournament fundraiser Saturday at the Texas National Golf Course, located at 8720 Club House Drive in Willis, along with a barbecue lunch, to benefit Shriver, who is suffering from embryonal carcinoma.ThermoDox In Combination With Radio Frequency Ablation Liver Phase I Results Presented At WCIO 2008 & Best Of ASCO Sun, 29 Jun 2008 09:13:32 GMT Celsion Corporation (NASDAQ: CLN) announced today that the interim results from its second Phase I liver cancer confirmation study of ThermoDox in combination with Radio Frequency Ablation (RFA) treating patients with primary and metastatic liver cancer were presented at both Oral and Poster presentation at the WCIO 2008 and Best of ASCO® conference.Weekend Doctor Sun, 29 Jun 2008 04:28:21 GMT By Dr. James ByattA day after bike ride in her honor, Terri Evans dies Sat, 28 Jun 2008 21:14:25 GMT HILLIARD - Terri Evans lost her fight with breast cancer Sunday, one day after hundreds gathered at Peters Point in Fernandina Beach to honor her with a 90-mile motorcycle ride. She was 47. Thallion Receives Health Canada Approval To Initiate Phase II Study For TLN-232 In Metastatic Melanoma Patients Sat, 28 Jun 2008 20:12:42 GMT Thallion Pharmaceuticals Inc. (TSX:TLN) announced it has received authorization from the Therapeutic Products Directorate of Health Canada to initiate a Phase II clinical trial evaluating TLN-232 as a treatment for metastatic melanoma in patients that have failed at least one prior therapy. The TLN-232 trial is the second Phase II study to be initiated this year from Thallion's oncology pipeline.Taming, Then Aiming, Viruses At Brain Tumors - "Engineered" Viruses May Hold Promise For Cancer Treatment Sat, 28 Jun 2008 10:13:55 GMT It may sound like the plot of a medical drama, but this approach to fighting cancer is real. Scientists say they may someday be able to battle brain cancer, while using a virus to do it. Early results from the lab are promising. The science itself may be complex, but the idea is relatively simple; modify a common virus that will bypass healthy cells and attack tumors.Solid Tumor Space Companies Examined in Wall Street Transcript Biotechnology Report Fri, 27 Jun 2008 15:34:00 GMT 67 WALL STREET, New York - June 27, 2008 - The Wall Street Transcript has just published its Biotechnology issue, a report offering a timely review of the sector to serious investors and industry executives. This 81-page feature contains a roundtable forum and industry commentary through in depth interviews with CEOs from 13 firms and 2 analysts. The full issue is available by calling (212) ...GlaxoSmithKline, Exelixis to end 6-year collaboration Fri, 27 Jun 2008 17:14:45 GMT Exelixis Inc.'s six-year drug development collaboration with GlaxoSmithKline will come to an end Oct. 27. (GSK) (EXEL)Gambia: Woman, 32 Needs Urgent Help Fri, 27 Jun 2008 16:59:25 GMT Haddy Joof has been battling a breast disorder for 3 years and needs urgent help to undergo further treatment in Dakar, Senegal..Liver Phase I Results Presented at WCIO 2008 & Best of ASCO(R) Fri, 27 Jun 2008 15:55:41 GMT CELSION CORPORATION (NASDAQ: CLN) announced today that the interim results from its second Phase I liver cancer confirmation study of ThermoDox in combination with Radio Frequency Ablation (RFA) treating patients with primary and metastatic liver cancer were presented at both Oral and Poster presentation at the WCIO 2008 and Best of ASCO(R) conference. The presentation provided Phase I interim ...Health Care and Banking Fri, 27 Jun 2008 16:20:00 GMT Whether an Obama administration or a McCain administration moves into the White House on Jan. 20, both candidates are promising to change the way health care is delivered in this country.My Pharmiweb.com Fri, 27 Jun 2008 10:21:29 GMT Oslo, Norway, 27 June 2008: Photocure ASA announces today that Metvixia(TM) in combination with Aktilite® CL128, the LED based narrow band (630 nm) red light technology device has been approved by US Food and Drug Administration (FDA) for the treatment of actinic keratosis (AK), a pre-cancerous skin lesion. |
Infectious and parasitic diseases |
|
|
< Home > |
||